Evidence map›Paper›PMID 33619859›Full record

ArticleJournal of magnetic resonance imaging : JMRI2021

Reducing Contrast Agent Dose in Cardiovascular MR Angiography with Deep Learning.

Javier Montalt-Tordera, Michael Quail, Jennifer A Steeden, Vivek Muthurangu

Open access · hybridAbstract read
In one paragraph

Article in Journal of magnetic resonance imaging : JMRI, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed, 1 pooled it
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 1 synthesis or guideline pooled it, 30 citations in OpenAlex.

  1. Society for Cardiovascular Magnetic Resonance recommendations toward environmentally sustainable cardiovascular magnetic resonance.Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance · 2025
    Guideline
  2. Article
  3. Review
  4. Review
  5. Review
  6. Review
  7. Article
  8. AI for image quality and patient safety in CT and MRI.European radiology experimental · 2025
    Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. ΔR1Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Javier Montalt-TorderaCentre for Cardiovascular Imaging, UCL Institute of Cardiovascular Science, University College London, London, WC1N 1EH, UK.ORCID 0000-0003-1956-1409
Michael QuailCentre for Cardiovascular Imaging, UCL Institute of Cardiovascular Science, University College London, London, WC1N 1EH, UK.
Jennifer A SteedenCentre for Cardiovascular Imaging, UCL Institute of Cardiovascular Science, University College London, London, WC1N 1EH, UK.
Vivek MuthuranguCentre for Cardiovascular Imaging, UCL Institute of Cardiovascular Science, University College London, London, WC1N 1EH, UK.
University College London · GBGreat Ormond Street Hospital · GB

Funding

British Heart Foundation NH/18/1/33511Heart Research UKKidney Research UKMedical Research Council MR/S032290/1UK Research and Innovation
6 · The paper itself

Abstract

backgroundContrast-enhanced magnetic resonance angiography (MRA) is used to assess various cardiovascular conditions. However, gadolinium-based contrast agents (GBCAs) carry a risk of dose-related adverse effects. PURPOSE: To develop a deep learning method to reduce GBCA dose by 80%. STUDY TYPE: Retrospective and prospective. POPULATION: A total of 1157 retrospective and 40 prospective congenital heart disease patients for training/validation and testing, respectively. FIELD STRENGTH/SEQUENCE: A 1.5 T, T1-weighted three-dimensional (3D) gradient echo. ASSESSMENT: A neural network was trained to enhance low-dose (LD) 3D MRA using retrospective synthetic data and tested with prospective LD data. Image quality for LD (LD-MRA), enhanced LD (ELD-MRA), and high-dose (HD-MRA) was assessed in terms of signal-to-noise ratio (SNR), contrast-to-noise ratio (CNR), and a quantitative measure of edge sharpness and scored for perceptual sharpness and contrast on a 1-5 scale. Diagnostic confidence was assessed on a 1-3 scale. LD- and ELD-MRA were assessed against HD-MRA for sensitivity/specificity and agreement of vessel diameter measurements (aorta and pulmonary arteries). STATISTICAL TESTS: SNR, CNR, edge sharpness, and vessel diameters were compared between LD-, ELD-, and HD-MRA using one-way repeated measures analysis of variance with post-hoc t-tests. Perceptual quality and diagnostic confidence were compared using Friedman's test with post-hoc Wilcoxon signed-rank tests. Sensitivity/specificity was compared using McNemar's test. Agreement of vessel diameters was assessed using Bland-Altman analysis.

resultsSNR, CNR, edge sharpness, perceptual sharpness, and perceptual contrast were lower (P < 0.05) for LD-MRA compared to ELD-MRA and HD-MRA. SNR, CNR, edge sharpness, and perceptual contrast were comparable between ELD and HD-MRA, but perceptual sharpness was significantly lower. Sensitivity/specificity was 0.824/0.921 for LD-MRA and 0.882/0.960 for ELD-MRA. Diagnostic confidence was 2.72, 2.85, and 2.92 for LD, ELD, and HD-MRA, respectively (P DATA

conclusionDeep learning can improve contrast in LD cardiovascular MRA. LEVEL OF EVIDENCE LEVEL: 2 TECHNICAL EFFICACY: Stage 2.

Indexed as

Contrast MediaDeep LearningHumansImaging, Three-DimensionalMagnetic Resonance AngiographyProspective StudiesReducing AgentsRetrospective StudiesContrast MediaReducing Agentscontrast agentdeep learninglow-dose MRAMR angiography

Identifiers

PMID33619859
PMCPMC9681557
OpenAlexW3129601406

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.